Citation Tools
PDFRegular and young investigator award abstracts
Immune-stimulants and immune modulators
587 Tumor-activated Fc-engineered anti-CTLA-4 monoclonal antibody, XTX101, demonstrates tumor-selective PD and efficacy in preclinical models
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- 587 Tumor-activated Fc-engineered anti-CTLA-4 monoclonal antibody, XTX101, demonstrates tumor-selective PD and efficacy in preclinical models